A retrospective study to evaluate toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas
Latest Information Update: 06 Mar 2020
At a glance
- Drugs Bevacizumab (Primary) ; Carmustine (Primary)
- Indications Glioma
- Focus Adverse reactions
Most Recent Events
- 06 Mar 2020 New trial record